Recent research reveal the promise of RMP1-14, a newly engineered anti-mouse PD-1 therapeutic, for enhancing tumor immune response . Unlike existing approaches, RMP1-14 exhibits enhanced interaction https://bookmarks-hit.com/story25384628/employing-rmp1-14-a-new-mouse-programmed-death-1-agent-for-immunotherapy